跳至主要内容
临床试验/CTRI/2024/10/075239
CTRI/2024/10/075239尚未招募4 期

Comparing treatment efficacy between recombinant FSH LH and recombinant FSH Highly purified human menopausal gonadotropins(HMG) A Prospective randomized controlled study.

Archana S1 个研究点 分布在 1 个国家目标入组 390 人开始时间: 2024年10月15日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
390
试验地点
1
主要终点
Quality of oocytes assessed on the day of oocyte pick up

研究概览

简要总结

HMG injeections and recombinant injections are used in the process of invitro fertilisation. in our study we strive to study whether giving a combination of recombinant FSH and recombinant LH improves the quality of oocytes and improves clinical pregnancy rate. To validate the paramount significance of rLH in influencing key aspects such as follicular development, oocyte and embryo quality, pregnancy and implantation rates

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
22.00 Year(s) 至 44.00 Year(s)(—)
性别
Female

入选标准

  • BMI 18-35 kg/m 2 Unexplained subfertility Male Factor subfertility.

排除标准

  • Oocyte donor patients Congenital uterine anomalies uncorrected septum Patient with endometriosis grade3&4 SOAT, Necrozoospermia.

结局指标

主要结局

Quality of oocytes assessed on the day of oocyte pick up

时间窗: Following 10-11 days of stimulation, once the follicle reaches more than 18 mm, trigger injection is given to induce ovualtion and maturation of follicles. oocyte pickup done 35 hours after trigger injection. after oocyte pickup, following denudation quality of oocytesis assessed on the same day.

次要结局

  • Oocyte maturity rate, ICSI normal fertilization(rate, Blastocyst development rate, Clinical Pregnancy)

研究者

发起方
Archana S
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Archana S

A4 Hospital and Fertility centre

研究点 (1)

Loading locations...

相似试验